vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and Ralliant Corp (RAL). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $529.1M, roughly 1.2× Ralliant Corp). Ralliant Corp runs the higher net margin — 7.5% vs 3.3%, a 4.2% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs -0.5%). Ralliant Corp produced more free cash flow last quarter ($126.6M vs $-2.5M).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
HIMS vs RAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $617.8M | $529.1M |
| Net Profit | $20.6M | $39.9M |
| Gross Margin | 71.9% | 50.8% |
| Operating Margin | 1.5% | 9.8% |
| Net Margin | 3.3% | 7.5% |
| Revenue YoY | 28.4% | -0.5% |
| Net Profit YoY | -20.8% | -56.1% |
| EPS (diluted) | $0.08 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $617.8M | — | ||
| Q3 25 | $599.0M | $529.1M | ||
| Q2 25 | $544.8M | $503.3M | ||
| Q1 25 | $586.0M | — | ||
| Q4 24 | $481.1M | — | ||
| Q3 24 | $401.6M | $531.7M | ||
| Q2 24 | $315.6M | $533.7M | ||
| Q1 24 | $278.2M | — |
| Q4 25 | $20.6M | — | ||
| Q3 25 | $15.8M | $39.9M | ||
| Q2 25 | $42.5M | $47.6M | ||
| Q1 25 | $49.5M | — | ||
| Q4 24 | $26.0M | — | ||
| Q3 24 | $75.6M | $90.9M | ||
| Q2 24 | $13.3M | $64.8M | ||
| Q1 24 | $11.1M | — |
| Q4 25 | 71.9% | — | ||
| Q3 25 | 73.8% | 50.8% | ||
| Q2 25 | 76.4% | 49.3% | ||
| Q1 25 | 73.5% | — | ||
| Q4 24 | 76.8% | — | ||
| Q3 24 | 79.2% | 52.6% | ||
| Q2 24 | 81.3% | 51.5% | ||
| Q1 24 | 82.4% | — |
| Q4 25 | 1.5% | — | ||
| Q3 25 | 2.0% | 9.8% | ||
| Q2 25 | 4.9% | 11.7% | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 5.6% | 20.9% | ||
| Q2 24 | 3.5% | 19.7% | ||
| Q1 24 | 3.6% | — |
| Q4 25 | 3.3% | — | ||
| Q3 25 | 2.6% | 7.5% | ||
| Q2 25 | 7.8% | 9.5% | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 18.8% | 17.1% | ||
| Q2 24 | 4.2% | 12.1% | ||
| Q1 24 | 4.0% | — |
| Q4 25 | $0.08 | — | ||
| Q3 25 | $0.06 | $0.35 | ||
| Q2 25 | $0.17 | $0.42 | ||
| Q1 25 | $0.20 | — | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.32 | $0.81 | ||
| Q2 24 | $0.06 | $0.57 | ||
| Q1 24 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.6M | $264.2M |
| Total DebtLower is stronger | — | $1.1B |
| Stockholders' EquityBook value | $540.9M | $3.0B |
| Total Assets | $2.2B | $5.3B |
| Debt / EquityLower = less leverage | — | 0.39× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $228.6M | — | ||
| Q3 25 | $345.8M | $264.2M | ||
| Q2 25 | $1.1B | $198.6M | ||
| Q1 25 | $273.7M | — | ||
| Q4 24 | $220.6M | — | ||
| Q3 24 | $165.5M | — | ||
| Q2 24 | $129.3M | — | ||
| Q1 24 | $105.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $540.9M | — | ||
| Q3 25 | $581.0M | $3.0B | ||
| Q2 25 | $562.7M | $3.0B | ||
| Q1 25 | $549.3M | — | ||
| Q4 24 | $476.7M | — | ||
| Q3 24 | $440.1M | $4.0B | ||
| Q2 24 | $362.0M | $4.0B | ||
| Q1 24 | $344.5M | — |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $5.3B | ||
| Q2 25 | $1.9B | $5.2B | ||
| Q1 25 | $891.7M | — | ||
| Q4 24 | $707.5M | — | ||
| Q3 24 | $602.3M | — | ||
| Q2 24 | $480.5M | — | ||
| Q1 24 | $448.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.38× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.3M | $138.6M |
| Free Cash FlowOCF − Capex | $-2.5M | $126.6M |
| FCF MarginFCF / Revenue | -0.4% | 23.9% |
| Capex IntensityCapex / Revenue | 10.3% | 2.3% |
| Cash ConversionOCF / Net Profit | 2.98× | 3.47× |
| TTM Free Cash FlowTrailing 4 quarters | $57.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $61.3M | — | ||
| Q3 25 | $148.7M | $138.6M | ||
| Q2 25 | $-19.1M | — | ||
| Q1 25 | $109.1M | — | ||
| Q4 24 | $86.4M | — | ||
| Q3 24 | $85.3M | — | ||
| Q2 24 | $53.6M | — | ||
| Q1 24 | $25.8M | — |
| Q4 25 | $-2.5M | — | ||
| Q3 25 | $79.3M | $126.6M | ||
| Q2 25 | $-69.5M | — | ||
| Q1 25 | $50.1M | — | ||
| Q4 24 | $59.5M | — | ||
| Q3 24 | $79.4M | — | ||
| Q2 24 | $47.6M | — | ||
| Q1 24 | $11.8M | — |
| Q4 25 | -0.4% | — | ||
| Q3 25 | 13.2% | 23.9% | ||
| Q2 25 | -12.8% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | 19.8% | — | ||
| Q2 24 | 15.1% | — | ||
| Q1 24 | 4.3% | — |
| Q4 25 | 10.3% | — | ||
| Q3 25 | 11.6% | 2.3% | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | 10.1% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 5.0% | — |
| Q4 25 | 2.98× | — | ||
| Q3 25 | 9.43× | 3.47× | ||
| Q2 25 | -0.45× | — | ||
| Q1 25 | 2.20× | — | ||
| Q4 24 | 3.32× | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 4.03× | — | ||
| Q1 24 | 2.32× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIMS
Segment breakdown not available.
RAL
| Industrial Manufacturing | $111.1M | 21% |
| Defense And Space | $93.6M | 18% |
| Diversified Electronics | $91.0M | 17% |
| Test And Measurement | $76.8M | 15% |
| Communications | $60.7M | 11% |
| Semiconductors | $51.4M | 10% |
| Other Direct End Markets | $44.4M | 8% |
